Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

Université de Montréal

$29,000.00

Characterization of the antibacterial activity of some antimicrobial-derived metabolites and their involvement in the development of antimicrobial resistance in bacteria of animal origin

FY 2024-25

Summary
Often described as the "quintessential One Health issue," antimicrobial resistance (AMR) is a global concern that poses a serious threat to human, animal, and environmental health. How the livestock sector contributes to the spread of AMR continues to be studied, with results pointing to the misuse of antimicrobials in farm animals having an impact on the selection of drug-resistant bacteria. The phenotypic and molecular study of AMR in bacteria of animal origin is often based on assessing the link between antimicrobials (parent molecules) and the AMR pattern of these bacteria. It is still mostly unknown if antimicrobial metabolites - released after the biodegradation of parent molecules within the animal - are involved in the selection and development of AMR. My proposal therefore aims to characterize, for the first time in pigs, both the in vitro and in vivo antibacterial activity of the major metabolites derived from some medically important antimicrobials (MIAs) and to characterize the evolution of bacterial resistance to these compounds compared to their parent molecules. Bacterial susceptibility to the MIAs and their metabolites will be assessed using the broth microdilution method, and genotypic characterization of AMR bacteria will be performed mostly using the Polymerase Chain Reaction (PCR). A continuous fermentation model will be used to characterize the stability of antimicrobial metabolites in conditions mimicking those found in swine intestines. An experimental post-weaning diarrhea model will be used to characterize in vivo both the antibacterial activity and the selection of AMR bacteria following the oral administration of the major antimicrobial-derived metabolites or their parent molecules. The most innovative molecular methods (high throughput sequencing, whole genome sequencing, whole-metagenome shotgun sequencing, etc.) will be used in this research program. We anticipate that some antimicrobial-derived metabolites will be associated with significant antibacterial activity and are involved in the selection of AMR bacteria, while they persist longer in a pig's body than their parent molecules. My research program will generate new findings under real field conditions, will provide data on better controlling AMR spread through the food chain, will develop a proof of concept to define a microbiological withdrawal period for antimicrobials used in pigs, and will produce ground-breaking advances in the characterization of antimicrobial-derived metabolites and their persistence in the bodies of pigs. These contributions will be useful to researchers, veterinarians, and producers in Canada and around the world in our global effort to contend with the major public health threat that AMR poses. To help achieve these goals, I will ensure that Highly Qualified Personnel (HQP) are trained and that the program will expand to become an international reference laboratory specialized in the study of antimicrobial-derived metabolites.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2022-04264
Name nom
Rhouma, Mohamed
Department département
Pathologie et microbiologie
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2022
Award amount
29000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
102
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal management (animal diseases, breeding)
Area of application fr
Gestion des animaux (maladies animales, reproduction)
Research subject code
5201
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Bacteriology
Research subject fr
Bactériologie
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Characterization of the antibacterial activity of some antimicrobial-derived metabolites and their involvement in the development of antimicrobial resistance in bacteria of animal origin
Keywords
antimicrobials; metabolites; antibacterial activity; antimicrobial resistance; e. coli; pigs; microbiota; residues; food safety
Application summary
Often described as the "quintessential One Health issue," antimicrobial resistance (AMR) is a global concern that poses a serious threat to human, animal, and environmental health. How the livestock sector contributes to the spread of AMR continues to be studied, with results pointing to the misuse of antimicrobials in farm animals having an impact on the selection of drug-resistant bacteria. The phenotypic and molecular study of AMR in bacteria of animal origin is often based on assessing the link between antimicrobials (parent molecules) and the AMR pattern of these bacteria. It is still mostly unknown if antimicrobial metabolites - released after the biodegradation of parent molecules within the animal - are involved in the selection and development of AMR. My proposal therefore aims to characterize, for the first time in pigs, both the in vitro and in vivo antibacterial activity of the major metabolites derived from some medically important antimicrobials (MIAs) and to characterize the evolution of bacterial resistance to these compounds compared to their parent molecules. Bacterial susceptibility to the MIAs and their metabolites will be assessed using the broth microdilution method, and genotypic characterization of AMR bacteria will be performed mostly using the Polymerase Chain Reaction (PCR). A continuous fermentation model will be used to characterize the stability of antimicrobial metabolites in conditions mimicking those found in swine intestines. An experimental post-weaning diarrhea model will be used to characterize in vivo both the antibacterial activity and the selection of AMR bacteria following the oral administration of the major antimicrobial-derived metabolites or their parent molecules. The most innovative molecular methods (high throughput sequencing, whole genome sequencing, whole-metagenome shotgun sequencing, etc.) will be used in this research program. We anticipate that some antimicrobial-derived metabolites will be associated with significant antibacterial activity and are involved in the selection of AMR bacteria, while they persist longer in a pig's body than their parent molecules. My research program will generate new findings under real field conditions, will provide data on better controlling AMR spread through the food chain, will develop a proof of concept to define a microbiological withdrawal period for antimicrobials used in pigs, and will produce ground-breaking advances in the characterization of antimicrobial-derived metabolites and their persistence in the bodies of pigs. These contributions will be useful to researchers, veterinarians, and producers in Canada and around the world in our global effort to contend with the major public health threat that AMR poses. To help achieve these goals, I will ensure that Highly Qualified Personnel (HQP) are trained and that the program will expand to become an international reference laboratory specialized in the study of antimicrobial-derived metabolites.